Prior to the end of 2004 LecTec was a health care and consumer products company that manufactured products based on its advance skin interface technologies. Its primary products included a line of over-the-counter therapeutic patches.

After completing all of its manufacturing contracts with
customers in December 2004, LecTec ceased all manufacturing activities and became an intellectual property licensing and holding company. The Company's primary focus is to obtain royalty income through licensing agreements related to patents that they own based on its advanced skin interface technologies. We are innovator in hyrogel-based topical delivery of therapeutic OTC medications, which provide alternative to topical creams and ointments. A hyrogel is a gel-llike material having an affinity for water and similar compounds. These gels are ideal for delivering medication onto the skin.